Brian Ellacott
About Brian Ellacott
Brian Ellacott serves as the Chief Executive Officer of Belmont Medical Technologies, a position he has held since 2017. He has extensive experience in leadership roles within the medical technology sector, having previously worked at Invacare in various executive capacities.
Work at Belmont Medical Technologies
Brian Ellacott has served as the Chief Executive Officer of Belmont Medical Technologies since 2017. Under his leadership, the company has focused on advancing medical technology solutions. His tenure has been marked by strategic initiatives aimed at enhancing operational efficiency and expanding market presence. Belmont Medical Technologies operates from Billerica, Massachusetts, where Ellacott oversees various aspects of the organization, including product development and corporate strategy.
Previous Experience at Invacare
Before joining Belmont Medical Technologies, Brian Ellacott held several key positions at Invacare Corporation. He was the Vice President and General Manager of Commercial Operations for North and South America from 2010 to 2012. Prior to that, he served as President of Invacare Canada LP in 2005 and 2006. Additionally, he was the Vice President of Sales and Marketing at Invacare from 2004 to 2005. His roles at Invacare involved overseeing operations and driving sales strategies across various markets.
Education and Expertise
Brian Ellacott earned a Bachelor of Business Administration (B.B.A.) degree in Business and Economics from Wilfrid Laurier University, where he studied from 1976 to 1980. His educational background has equipped him with the knowledge necessary for effective leadership in the medical technology sector. He possesses expertise in organizational restructuring, strategic planning, and partnership development, which are critical for enhancing business performance.
Leadership and Business Growth
Brian Ellacott has extensive experience in building and directing leadership teams within Fortune 500 and private equity-controlled businesses. He has a proven track record of growing organizations both organically and through acquisitions. His focus on strategic planning and execution has contributed to the success of the companies he has led, ensuring they remain competitive in the evolving medical technology landscape.